Regeneron Pharmaceuticals
REGN
#299
Rank
S$99.87 B
Marketcap
S$942.35
Share price
-1.07%
Change (1 day)
3.72%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$0 M-100%
2025S$69.45 M-20.85%
2024S$87.75 M-26.52%
2023S$0.11 B-5.6%
2022S$0.12 B-53.05%
2021S$0.26 B5.23%
2020S$0.25 B414.86%
2019S$49.73 M-31.98%
2018S$73.11 M69.52%
2017S$43.12 M-78.72%
2016S$0.20 B3.03%
2015S$0.19 B-15.29%
2014S$0.23 B419.89%
2013S$44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
S$24.94 MS$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$93.01 MS$0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$0.20 BS$0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$10.89 MS$69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$3.4 MS$75.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$9.93 MS$38.5 M๐Ÿ‡บ๐Ÿ‡ธ USA